36
Views
0
CrossRef citations to date
0
Altmetric
Research

Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda

, , , & ORCID Icon
Article: 36 | Received 05 Jul 2019, Accepted 17 Oct 2019, Published online: 28 Nov 2023

References

  • Ministry of Health. National Medicines Policy of Uganda. 2015;(july):38. [Accessed April 28 2019] http://apps.who.int/medicinedocs/en/m/abstract/Js22314en/
  • Windisch R, Waiswa P, Neuhann F, Scheibe F, de Savigny D. Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening. Glob Health. 2011;7(1):25.https://doi.org/10.1186/1744-8603-7-25.
  • Ministry of Health Uganda. Uganda Pharmaceutical Sector Report 2010.; 2010. [Accessed April 28 2019] http://library.health.go.ug/publications/medical-products-technologies/pharmaceuticals-and-drugs/uganda-pharmaceutical-sector.
  • Ministry of Health Uganda. Uganda Pharmaceutical Sector Report 2011.; 2011. [Accessed April 28 2019] http://health.go.ug/content/uganda-pharmaceutical-sector-report-2011.
  • Trap B, Kikule K, Vialle-Valentin C, et al. First regulatory inspections measuring adherence to good pharmacy practices in the public sector in Uganda : a cross-sectional comparison of performance between supervised and unsupervised facilities. J Pharm Policy Pract. 2016;9(18):1–10.https://doi.org/10.1186/s40545-016-0068-4.
  • UBOS. Uganda National Household Survey (UNHS) 2016/17. 2017;(September):272. [Accessed April 28 2019] http://www.ubos.org/onlinefiles/uploads/ubos/pdf documents/UNHS_VI_2017_Version_I_ 27th_September_2017.pdf.
  • Ministry of Health U. Health Sector Development Plan 2015/16–2019/20.; 2015. [Accessed April 28 2019] http://health.go.ug/content/health-sector-development-plan-201516-201920
  • Ministry of Finance Planning and Economic Development. Millennium Development Goals Report for Uganda 2013. Vol 1.; 2015. [Accessed April 28 2019] http://www.undp.org/content/dam/uganda/docs/UNDPUg-2013MDGProgress Report-Oct 2013.pdf.
  • Ministry of Health Uganda. Annual Pharmaceutical Sector Performance Report 2015–2016.; 2017. [Accessed April 28 2019] http://health.go.ug/content/annual-pharmaceutical-sector-performance-report-2015-2016-0.
  • Ministry of Health. Annual Pharmaceutical Sector Performace Report 2014/15. 2015;(June). [Accessed April 28 2019] http://health.go.ug/content/annual-pharmaceutical-sector-performance-report
  • Kwesiga B, Wagner A, Seru M, Trap B. Equitable Access to High-Cost Pharmaceuticals Capter 8: Improving Access to High-Cost Medicines in Low Income Countries in Africa: Creating a Functioning Pharmaceutical System In Uganda. (Zaheer-Ud-Din B, ed.). Academic Press Elsevier; 125 London Wall, London EC2Y 5AS, United Kingdom; 2018.
  • Trap B, Ladwar DO, Oteba MO, Embrey M, Khalid M, Wagner AK. Article 1: supervision, performance assessment, and recognition strategy (SPARS) - a multipronged intervention strategy for strengthening medicines management in Uganda: method presentation and facility performance at baseline. J Pharm Policy Pract. 2016;9(1):1–15.https://doi.org/10.1186/s40545-016-0070-x.
  • Ministry of Health, Pharmacy Department U. National Performance Report on Medicines Management April–June 2015 [Accessed April 28 2019] https://www.health.go.ug/download/file/fid/547
  • Trap B, Musoke R, Kirunda A, Oteba MO, Embrey M, Ross-Degnan D. Article 2: Longitudinal study assessing the one-year effects of supervision performance assessment and recognition strategy (SPARS) to improve medicines management in Uganda health facilities. J Pharm Policy Pract. 2018;11(1). https://doi.org/10.1186/s40545-018-0142-1.
  • Suraratdecha C, Ramana CV, Kaipilyawar S, et al. Cost and effectiveness analysis of immunization service delivery support in Andhra Pradesh. India Bull World Health Organ. 2008;86(3):221–228.https://doi.org/10.2471/BLT.06.039495.
  • Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies. Value Heal. 2018:1–3. https://doi.org/10.1016/j.jval.2017.12.016.
  • Management Sciences for Health. MDS-3: Managing Access to Medicines and Health Technologies.; 2012. [Accessed April 28 2019] http://apps.who.int/medicinedocs/documents/s19577en/s19577en.pdf
  • Chukwu OA, Ezeanochikwa VN, Eya BE. Supply chain management of health commodities for reducing global disease burden. Res Soc Adm Pharm. 2017;13(4):871–874. https://doi.org/10.1016/j.sapharm.2016.08.008Get rights and content.
  • Seidman G, Atun R. Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals , vaccines or health products ? A systematic review of evidence from low-income and middle-income countries. BMJ Glob Heal. 2017;2(e000243):1–14.https://doi.org/10.1136/bmjgh-2016-000243.
  • Ministry of Health Uganda. Policy Options Analysis for Uganda’s Pharmaceutical Supply System.; 2010. [Accessed April 28 2019] https://pdf.usaid.gov/pdf_docs/PA00JTFG.pdf
  • Oteba M, Wagner AK, Seru M, Embrey M, Trap B. Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy. J Pharm Policy Pract. 2018;11(1):23.https://doi.org/10.1186/s40545-018-0150-1.